Osteoarthritis and chronic pain: Interleukin-6 as a common denominator and therapeutic target

Drugs that target IL-6 effectors may be useful for osteoarthritis therapy (Liao et al., in 26 July 2022 issue).
Source: Signal Transduction Knowledge Environment - Category: Science Source Type: news